Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a trailblazer in the biotechnology sector, has captured investor attention with a notable potential upside of 210.41%, according to recent analyst ratings. As a commercial-stage..
iRadimed Corporation (NASDAQ: IRMD), a prominent player in the healthcare sector, specializes in developing MRI-compatible medical devices. Headquartered in Orlando, Florida, the company has carved out a niche within the..
Butterfly Network, Inc. (NASDAQ: BFLY) is making waves in the healthcare sector, particularly in the niche of medical devices. With a current market capitalization of $1.19 billion, Butterfly Network is..
Arcus Biosciences, Inc. (NASDAQ: RCUS), a clinical-stage biopharmaceutical company, has been making waves in the biotechnology sector with its promising cancer therapies. With a current market capitalization of $2.85 billion,..
Fulgent Genetics, Inc. (NASDAQ: FLGT) is positioning itself as a promising player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in El Monte, California, Fulgent Genetics..
Avadel Pharmaceuticals plc (NASDAQ: AVDL) has been capturing the attention of investors within the healthcare sector, specifically those focusing on specialty and generic drug manufacturers. This Ireland-based biopharmaceutical company, with..
Phibro Animal Health Corporation (NASDAQ: PAHC) stands out in the healthcare sector as a key player in the drug manufacturers – specialty and generic industry. With a market capitalization of..
Spyre Therapeutics, Inc. (NASDAQ: SYRE), a burgeoning name in the healthcare sector, is capturing the attention of investors with its promising prospects in the biotechnology industry. Specializing in innovative treatments..
Nutex Health Inc. (NASDAQ: NUTX) has emerged as a noteworthy player in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization of $1.13 billion, Nutex..
For investors seeking exposure to the cutting-edge healthcare sector, Beta Bionics, Inc. (NASDAQ: BBNX) offers a compelling opportunity with significant growth potential. This commercial-stage medical device company, based in Irvine,..
Intellia Therapeutics, Inc. (NASDAQ: NTLA), a trailblazer in the biotechnology sector, is captivating investor attention with its promising gene editing technologies and substantial growth potential. Headquartered in Cambridge, Massachusetts, Intellia..
CureVac N.V. (NASDAQ: CVAC), a prominent player in the biotechnology sector, has been navigating a complex landscape characterized by significant innovation and strategic shifts. As of December 18, 2025, the..
Geron Corporation (NASDAQ: GERN), a burgeoning name in the biotechnology sector, has recently captured the attention of investors with its significant upside potential. With a current market cap of $900.08..
Pharvaris N.V. (PHVS), a Swiss-based biopharmaceutical company, has emerged as a compelling player in the biotechnology sector, focusing on developing therapies for rare diseases. With a current market capitalization of..
Embecta Corp. (NASDAQ: EMBC), a prominent player in the healthcare sector, is gaining attention from investors due to its promising potential for a 37.97% upside. Specializing in medical instruments and..
For investors keen on tapping into the dynamic world of healthcare innovation, Akebia Therapeutics, Inc. (NASDAQ: AKBA) presents a particularly compelling opportunity. With its focus on developing therapeutics for kidney..
Nurix Therapeutics, Inc. (NASDAQ: NRIX), a promising player in the biotechnology sector, is capturing investor attention with its potential for significant upside. With a market capitalization of $1.97 billion, this..
HealthStream, Inc. (NASDAQ: HSTM), a prominent player in the Health Information Services industry, stands out as a compelling investment opportunity for those looking to navigate the healthcare sector. Headquartered in..
For investors seeking promising opportunities in the biotechnology sector, Niagen Bioscience, Inc. (NAGE) presents an intriguing prospect with a substantial potential upside. Listed in the healthcare sector and focused on..
Zymeworks Inc. (NASDAQ: ZYME) stands out as a formidable player in the biotech sector, driven by its innovative approach to cancer and autoimmune disease therapies. With a market capitalization of..
